Effectiveness of an Innovative Mobile-Based Perioperative Care Program for Women Undergoing Breast Cancer Surgery (iCareBreast): Randomized Controlled Trial (Preprint)
Authors:
- Yan PangYPYan Pang
- Honggu HeHHHonggu He
- Ruey-Pyng NgRNRuey-Pyng Ng
- Nicole Kim Luan LeeNLNicole Kim Luan Lee
- Me Me Win HteinMHMe Me Win Htein
- Xiao-Xin ZhaoXZXiao-Xin Zhao
- Ying-Hong LiYLYing-Hong Li
- Elizabeth Jiahui ChanECElizabeth Jiahui Chan
- Lixia ZhuLZLixia Zhu
- Guang Yu LiuGLGuang Yu Liu
- Minna PikkarainenMPMinna Pikkarainen
- Swee-Ho LimSLSwee-Ho Lim
Preprint
- 24 January 2025
- preprint
- Published by JMIR Publications Inc. in JMIR Preprints
Abstract
BACKGROUND Breast cancer is one of the most prevalent cancers among women and significantly impacts psychological well-being and health-related quality of life (HR-QoL) during the perioperative period. Mobile health interventions offer a promising approach to providing education and psychosocial support, yet their effectiveness in this context remains underexplored. OBJECTIVE This study aimed to develop and evaluate the effectiveness of an innovative, mobile-based, perioperative care program for women undergoing breast cancer surgery (iCareBreast). The assessment focused on perioperative self-efficacy, anxiety, depression, fatigue, HR-QoL, and perioperative care satisfaction. METHODS A two-group randomized control trial was conducted at a tertiary hospital in Singapore. The intervention group used the iCareBreast app, offering four main resources: perioperative care guidance, breast cancer and surgery education, psychological support, and social support. The control group received standard hospital care. Participants in the intervention group engaged with the fully automated app daily for 29 days (two weeks before surgery, on the day of surgery, and two weeks after surgery). Data were collected face-to-face or on the web at three time points: baseline, immediately after the intervention (T1; two weeks after surgery), and at a 2.5-month follow-up (T2; three months after surgery). The primary outcome was perioperative care self-efficacy, while secondary outcomes included anxiety, depression, fatigue, HR-QoL, and perioperative care satisfaction. RESULTS A total of 123 patients with early-stage breast cancer scheduled for breast surgery were enrolled in the study, with 62 patients assigned to the iCareBreast group and 61 patients to the control group. The results showed no significant differences between the groups in the primary outcome—perioperative self-efficacy—at any time point. Baseline scores were similar (P=.80), and while the iCareBreast group showed slightly lower scores at T1 (mean difference [MD] –1.63, 95% CI –3.43 to 0.18; P=.08) and T2 (MD –1.90, 95% CI –4.06 to 0.26; P=.09), the differences were not statistically significant. Similarly, secondary outcomes, including anxiety, depression, fatigue, HR-QoL, and perioperative care satisfaction, showed no significant changes between groups (all P>.05). However, the iCareBreast group reported higher perioperative care satisfaction during the postintervention assessment. Satisfaction scores were comparable at T1 (P=.68), while at T2, the iCareBreast group showed a slight increase compared to the control group (MD 0.35, 95% CI 0.04-0.73; P=.08), though the difference was not statistically significant. CONCLUSIONS The mobile-based psychosocial intervention, although satisfied by users, did not demonstrate significant benefits compared to standard care. This highlights the need to refine the iCareBreast app in future iterations to enhance its effectiveness in addressing the targeted health outcomes. Future mobile health research should prioritize optimizing user engagement strategies and incorporating personalized approaches to better address the perioperative care needs of patients with breast cancer. CLINICALTRIAL ClinicalTrials.gov NCT04172350; https://clinicaltrials.gov/study/NCT04172350Keywords
All Related Versions
- Published version: Journal of Medical Internet Research, 27 (1), e71684.
This publication has 52 references indexed in Scilit:
- Evaluating a digital tool for supporting people affected by breast cancer: a prospective randomized controlled trial—the ADAPT studySupportive Care in Cancer, 2024
- Guided versus non‐guided digital psychological interventions for cancer patients: A systematic review and meta‐analysis of engagement and efficacyPsycho-Oncology, 2024
- Psychological interventions for women with non-metastatic breast cancerCochrane Database of Systematic Reviews, 2023
- My health smartphone intervention decreases daily fat sources among Latina breast cancer survivorsJournal of Behavioral Medicine, 2020
- Brief culturally informed smartphone interventions decrease breast cancer symptom burden among Latina breast cancer survivorsPsycho-Oncology, 2019
- Treatment anxiety in breast cancer patientsArchives of Gynecology and Obstetrics, 2019
- Use of a web-based app to improve breast cancer symptom management and adherence for aromatase inhibitors: a randomized controlled feasibility trialJournal of Cancer Survivorship, 2018
- The efficacy of interventions to improve psychosocial outcomes following surgical treatment for breast cancer: a systematic review and meta-analysisPsycho-Oncology, 2016
- Symptom burden in cancer survivors 1 year after diagnosisCancer, 2011
- Sample Size Tables for Clinical Studies2008